England - East Anglia • Corporate and commercial
Goodwin
Goodwin's Cambridge office is a key hub for the firm-wide technology and life sciences practice, which has a prominent global profile. The firm advises private and public companies, venture capital funds and investment firms on early-stage financings, capital market transactions, M&A deals, strategic collaborations and licensing matters in this context. David Mardle, Malcolm Bates and Tim Worden are the lead partners. Adam Thatcher who was promoted to partner in October 2022 and Elizabeth Rhodes play key roles in tech in VC and M&A transaction work, namely. The team is noted as being ‘smart and responsive, with good depth of skill and experience in complex transactions'.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Knowledgeable on venture capital, extremely responsive, good risk mitigations.’
‘We have a genuine relationship with the team who always seek to understand circumstances and context.’
‘Smart and responsive, with good depth of skill and experience in complex transactions.’
‘A trusted advisor with breadth of experience, responsiveness and availability.'
‘Extensive experience of commercial transactions; a highly pragmatic approach, efficient and expeditious in providing advice. Excellent value for money.’
'Elizabeth Rhodes is extremely commercial and effective, and has a very talented group of associates including Roshni Thakkar, who deserves particular mention. The team is highly commercial with a focus on getting a deal done. They have proven excellent at learning how we as a client like to work with external advisers, and what our limits are, and now implement this consistently.'
'We trust the Cambridge team's judgement and have confidence in them striking the right balance between attention-to-detail and not overworking a matter. The team is well run, consistent in their approach, transitions are smooth and all are a pleasure to work with.'
'Elizabeth Rhodes is highly commercial, a clear and efficient communicator, and resilient in negotiations. She learns her clients, their preferences and limits, and ensures that she and her team take as much as they can upon themselves. Roshni Thakkar is excellent - technically completely sound, has a strong commercial outlook, with excellent communication and project management skills.'
Key clients
- Okra.ai
- Refeyn Limited
- Oxford Science Enterprises PLC
- Syncona Portfolio Limited
- Engitix Limited
- SynAffix B.V.
- Stalicla SA
- Probe Test Solutions Limited
- Ten Eleven Ventures
- MiroBio Ltd
- Flusso
- Cleo
- SV Health Investors
- Jeito
- Samsara BioCapital
- Biocon Biologics Ltd
- YASA
- Moderna
- Tay Therapeutics
Work highlights
- Advised OKRA.ai on their acquisition by Envision Pharma Group (Envision)
- Advised Refeyn on its oversubscribed Series B financing. The round was led by Northpond Ventures, a scientific, medical, and technology-driven venture firm and supported by existing investors, including Oxford Science Enterprises, Foresight Group, Oxford University and Horizons Ventures.
- Advised Oxford Science Enterprises PLC and Syncona Portfolio Limited on their investments into OMass Therapeutics Limited as part of OMass’s $100m Series B funding round alongside new investors GV, Northpond and Sanofi.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Next Generation Partners
Practice head
The lawyer(s) leading their teams.
Malcolm Bates, David Mardle, Tim Worden